Columbia University Irving Medical Center

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

• Columbia University Medical Center

  New York, New York 10032

  267 trials

• Columbia University Irving Medical Center

  New York, New York 10032

  255 trials

• Columbia University Medical Center/NYPH

  New York, New York 10032

  26 trials

• Columbia University Medical Center - Herbert Irving Pavilion

  New York, New York 10032

  10 trials

• Columbia University Irving Medical Center/NYPH

  New York, New York 10032

  7 trials

• NewYork-Presbyterian / Columbia University Irving Medical Center

  New York, New York 10032

  7 trials

• New York Presbyterian/Columbia University Medical Center

  New York, New York 10032

  7 trials

• Columbia University Irving Medical Center- Site Number : 8400003

  New York, New York 10032

  4 trials

• Columbia University Medical Center - Department of Pediatrics

  New York, New York 10032

  3 trials

  • NCT06363760A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

  • NCT05444894EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)

  • NCT04853576A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)

• Columbia University Medical Center - PIN

  New York, New York 10032

  3 trials

  • NCT06606340A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice

  • NCT03635073A Study of Soticlestat in Adults and Children With Rare Epilepsies

  • NCT02932410A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

• Columbia University Irving Medical Center - Pediatric Cardiology

  New York, New York 10032

  2 trials

  • NCT07192952A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

  • NCT07188805A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

• Columbia University Irving Medical Center- Site Number : 8400009

  New York, New York 10032

  2 trials

  • NCT07088068A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  • NCT05039840Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus

• Columbia University Irving Medical Center- Site Number : 840125

  New York, New York 10032

  2 trials

  • NCT00231400Pompe Disease Registry Protocol

    Contact: Pompe Registry HelpLine

  • NCT00358943International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

    Contact: ICGG Gaucher Registry HelpLine

• Columbia University Irving Medical Centre

  New York, New York 10032

  2 trials

  • NCT05546268Study of Oral MRT-2359 in Selected Cancer Patients

  • NCT05301335Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study

• Columbia University Medical Center (21+ years)

  New York, New York 10032

  2 trials

  • NCT03745287A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

  • NCT03655678A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia

• Columbia University Medical Center: Department of Medicine, Division of Rheumatology

  New York, New York 10032

  2 trials

  • NCT05201469VIBRANT: VIB4920 for Active Lupus Nephritis

    Contact: Ellen Montgomery

  • NCT05306873Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

• Columbia University Medical Center: Division of Pediatric Pulmonology

  New York, New York 10032

  2 trials

  • NCT06136091Protocol CAUSE-03 / CHEETAH

    Contact: Marcela Pierce

  • NCT05347771Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents

• Columbia University Medical Center/Neurological Institute

  New York, New York 10032

  2 trials

  • NCT05480228EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA

  • NCT05476276EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy

• Columbia University Medical Center_New York

  New York, New York 10032

  2 trials

  • NCT07567001A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

    Contact: Novo Nordisk

  • NCT04624659A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

• Columbia University Irving Medical Center

  Manhattan, New York 10032

  1 trial

  • NCT07225400Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive Impairment

    Contact: Sunil Agrawal, PhD

• Columbia University Irving Medical Center - 622 W 168th St

  New York, New York 10032

  1 trial

  • NCT05695027Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study

• Columbia University Irving Medical Center - 622 W. 168th St. Floor 18

  New York, New York 10032

  1 trial

  • NCT05992415Know Your Pressures NYC

    Contact: Lisa A. Hark, PhD, MBA

• Columbia University Irving Medical Center (Adults only)

  New York, New York 10032

  1 trial

  • NCT04554914A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

• Columbia University Irving Medical Center - Appendix A & B

  New York, New York 10032

  1 trial

  • NCT06305780RECOVER-AUTONOMIC Platform Protocol

• Columbia University Irving Medical Center: Department of Neurology, Multiple Sclerosis Center

  New York, New York 10032

  1 trial

  • NCT05000216COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

• Columbia University Irving Medical Center/Edward S. Harkness Eye Institute

  New York, New York 10032

  1 trial

  • NCT07290244Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)

    Contact: Ioannis Michalopoulos

• Columbia University Irving Medical Center - Herbert Irving Pavilion Site#104

  New York, New York 10032

  1 trial

  • NCT03975387Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53

• Columbia University Irving Medical Center - HIP

  New York, New York 10032

  1 trial

  • NCT02202772Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder

• Columbia University Irving Medical Center /ID# 235686

  New York, New York 10032

  1 trial

  • NCT04166058Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C

• Columbia University Irving Medical Center /ID# 268887

  New York, New York 10032

  1 trial

  • NCT05456685Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer

• Columbia University Irving Medical Center /ID# 269033

  New York, New York 10032

  1 trial

  • NCT05527184First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

• Columbia University Irving Medical Center /ID# 276156

  New York, New York 10032

  1 trial

  • NCT06890338A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

• Columbia University Irving Medical Center/New York Presbyterian

  New York, New York 10032

  1 trial

  • NCT05799378Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

    Contact: Mala Masson

• Columbia University Irving Medical Center/NewYork-Presbyterian

  New York, New York 10032

  1 trial

  • NCT06833320Propranolol Treatment for Postoperative Chylothorax

• Columbia University Irving Medical Center/NYP

  New York, New York 10032

  1 trial

  • NCT03719430APX005M and Doxorubicin in Advanced Sarcoma

• Columbia University - Irving Medical Center (Site #: 1008)

  New York, New York 10032

  1 trial

  • NCT05217628An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.

• Columbia University Irving Medical Center- Site Number : 157199

  New York, New York 10032

  1 trial

  • NCT00567073Pompe Pregnancy Sub-Registry

    Contact: Pompe Registry HelpLine

• Columbia University Irving Medical Center- Site Number : 8400001

  New York, New York 10032

  1 trial

  • NCT06500702A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

• Columbia University Irving Medical Center- Site Number : 8400088

  New York, New York 10032

  1 trial

  • NCT06141486Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

• Columbia University Irving Medical Center - The Neurological Institute of New York

  New York, New York 10032-3726

  1 trial

  • NCT06706622A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)

• Columbia University Med Center

  New York, New York 10032

  1 trial

  • NCT05232929Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)

• Columbia University Medical Center (Adults and Pediatrics)

  New York, New York 10032

  1 trial

  • NCT03394365A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

    Contact: Data Protection Officer

• Columbia University Medical Center - Center for Liver Disease and Transplantation

  New York, New York 10032

  1 trial

  • NCT04526665Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

• Columbia University Medical Center - CUMC

  New York, New York 10032

  1 trial

  • NCT05218655A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

• Columbia University Medical Center: Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine

  New York, New York 10032

  1 trial

  • NCT05272241Registry of Asthma Characterization and Recruitment 3 (RACR3)

• Columbia University Medical Center: Division of Nephrology

  New York, New York 10032

  1 trial

  • NCT03949855Belimumab With Rituximab for Primary Membranous Nephropathy

    Contact: Anup Pradhan

• Columbia University Medical Center, Division of Pediatric Endocrinology, Diabetes and Metabolism

  New York, New York 10032

  1 trial

  • NCT04966741Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

• Columbia University Medical Center, Div of Nephrology

  New York, New York 10032

  1 trial

  • NCT04128579Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

• Columbia University Medical Center/Edward Harkness Eye Institute

  New York, New York 10032

  1 trial

  • NCT045171494D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

• Columbia University Medical Center - Herbert Irving Center for Dermatology and Skin Cancer - Herbert Irving Pavilion

  New York, New York 10032

  1 trial

  • NCT06585410Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

    Contact: Clinical Trials Administrator

• Columbia University Medical Center /ID# 153661

  New York, New York 10032-3729

  1 trial

  • NCT02942290A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

• Columbia University Medical Center /ID# 200715

  New York, New York 10032-3729

  1 trial

  • NCT03539744A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

• Columbia University Medical Center /ID# 215122

  New York, New York 10032-3729

  1 trial

  • NCT04309474A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke

• Columbia University Medical Center /ID# 250189

  New York, New York 10032-3729

  1 trial

  • NCT05570006Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis

• Columbia University Medical Center /ID# 255068

  New York, New York 10032-3729

  1 trial

  • NCT06158854A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

• Columbia University Medical Center /ID# 258496

  New York, New York 10032-3729

  1 trial

  • NCT06257875A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

• Columbia University Medical Center /ID# 261879

  New York, New York 10032-3729

  1 trial

  • NCT06063967A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.

• Columbia University Medical Center /ID# 262587

  New York, New York 10032-3729

  1 trial

  • NCT06100744A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

    Contact: Site Coordinator

• Columbia University Medical Center /ID# 273518

  New York, New York 10032

  1 trial

  • NCT06880744A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

• Columbia University Medical Center /ID# 277990

  New York, New York 10032

  1 trial

  • NCT07059845A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

• Columbia University Medical Center /ID# 283510

  New York, New York 10032

  1 trial

  • NCT07728188A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

• Columbia University Medical Center: Naomi Berrie Diabetes Center

  New York, New York 10032

  1 trial

  • NCT05574335Siplizumab in T1DM

• Columbia University Medical Center - Neurological Institute, 710 W. 168th, 2nd floor, suite 204 - Site Number : 8400003

  New York, New York 10032

  1 trial

  • NCT06844214A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1

    Contact: Jorge Cabrera

• Columbia University Medical Center - Neurological Institute of New York

  New York, New York 10032

  1 trial

  • NCT05538130A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

• Columbia University Medical Center_New York_0

  New York, New York 10032

  1 trial

  • NCT06609226A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

    Contact: Novo Nordisk

• Columbia University Medical Center / NewYork-Presbyterian

  New York, New York 10032

  1 trial

  • NCT05855135Assessment of Combined CCM and ICD Device in HFrEF

• Columbia University Medical Center (Site 0010)

  New York, New York 10032

  1 trial

  • NCT05116189Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

• Columbia University Medical Center (Site 1800)

  New York, New York 10032

  1 trial

  • NCT03635567Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

• Columbia University Medical Center- Site Number : 8400013

  New York, New York 10032

  1 trial

  • NCT03560466Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)

• Columbia University Medical Center-Site Number: 8400138

  New York, New York 10032

  1 trial

  • NCT07184931An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

• Columbia University Medical Ctr

  New York, New York 10032

  1 trial

  • NCT05838768Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

• Columbia Univ Med Ctr

  New York, New York 10032

  1 trial

  • NCT03708328A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors

• Columbia Univ Medical Center /ID# 135052

  New York, New York 10032-3725

  1 trial

  • NCT01848561A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

• Columbia Univ Medical Center /ID# 144440

  New York, New York 10032-3725

  1 trial

  • NCT02130362A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

• Columbia Univ Medical Center /ID# 144475

  New York, New York 10032-3725

  1 trial

  • NCT02130362A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

• Columbia Univ Medical Center /ID# 145334

  New York, New York 10032-3725

  1 trial

  • NCT03213457A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

• Columbia Univ Medical Center /ID# 154101

  New York, New York 10032-3725

  1 trial

  • NCT02993523A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy

• Columbia Univ Medical Center /ID# 161519

  New York, New York 10032-3725

  1 trial

  • NCT03271489Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

• Columbia Univ Medical Center /ID# 161899

  New York, New York 10032-3725

  1 trial

  • NCT03105102A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

• Columbia Univ Medical Center /ID# 161929

  New York, New York 10032-3725

  1 trial

  • NCT03398135A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis

• Columbia Univ Medical Center /ID# 163409

  New York, New York 10032-3725

  1 trial

  • NCT03006068A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)

• Columbia Univ Medical Center /ID# 164692

  New York, New York 10032-3725

  1 trial

  • NCT03345823A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

• Columbia Univ Medical Center /ID# 217113

  New York, New York 10032-3725

  1 trial

  • NCT04333576Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

• Columbia Univ Medical Center /ID# 224215

  New York, New York 10032-3725

  1 trial

  • NCT04524611Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

• Columbia Univ Medical Center /ID# 233094

  New York, New York 10032-3725

  1 trial

  • NCT04026113Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)

• Neuroendocrine Unit; Columbia University Medical Center, 180 Fort Washington Avenue 9-970

  New York, New York 10032

  1 trial

  • NCT01809808A Prospective Study of Outcome After Therapy for Acromegaly

• The Neurological Institute - Columbia University Irving Medical Center

  New York, New York 10032

  1 trial

  • NCT05686070A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke